Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

ZITHROMAX 250 MG Z-PAK TABLET

azithromycin dihydrate
$2.0670per EA
High Outlier

Strength

250 mg/1

Manufacturer

Pfizer Inc.

NDC

00069306075

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

8/20/2025

Active Ingredients

AZITHROMYCIN DIHYDRATE

Approval Type

New Drug (NDA)

FDA Application

NDA050711

On Market Since

7/18/1996

Pharmacological Classes

Macrolide Antimicrobial
Macrolides

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

-0.6%

3Y

-0.7%

5Y

-93.7%

All

-85.7%

Generic Alternatives

1 alternative • Same active ingredient

ZITHROMAX 250 MG TABLET
Brand
00069406189•Pfizer Inc.
$2.0670

Related Drugs

Same classification

E.E.S. 200 MG/5 ML GRANULES
Brand
24338013610•Azurity Pharmaceuticals Inc.
$3.1656
per ML
ERYPED 200 MG/5 ML SUSPENSION
Brand
24338013213•Azurity Pharmaceuticals Inc.
$3.6046
per ML
E.E.S. 200 MG/5 ML SUSPENSION
Brand
24338013402•Azurity Pharmaceuticals Inc.
$3.6046
per ML
E.E.S. 200 MG/5 ML SUSPENSION
Brand
80005015218•Carnegie Pharmaceuticals LLC
$3.6046
per ML
ERYPED 400 MG/5 ML SUSPENSION
Brand
24338013013•Azurity Pharmaceuticals Inc.
$6.3072
per ML
ERYPED 400 MG/5 ML SUSPENSION
Brand
80005015518•Carnegie Pharmaceuticals LLC
$6.3072
per ML
AZASITE 1% EYE DROPS
Brand
82584030703•Thea Pharma Inc.
$98.3418
per ML
DIFICID 200 MG TABLET
Brand
52015008001•Merck Sharp & Dohme LLC
$248.6921
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy